-
1دورية أكاديمية
المؤلفون: Soares A; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil. dr.andrey@uol.com.br.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. dr.andrey@uol.com.br.; Centro Paulista de Oncologia/Oncoclínicas, São Paulo, SP, Brazil. dr.andrey@uol.com.br., Monteiro FSM; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Sírio-Libanês, Brasília, DF, Brazil., da Trindade KM; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Oncologia D'Or, Fortaleza, CE, Brazil., Silva AGE; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Instituto do Câncer e Transplante de Curitiba/PR (ICTr Curitiba), Curitiba, PR, Brazil., Cardoso APG; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Sasse AD; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Grupo SONHE de Campinas, Campinas, SP, Brazil., Fay AP; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Escola de Medicina da Pontifícia, Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil., Carneiro APCD; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Hospital Municipal Vila Santa Catarina, São Paulo, SP, Brazil., Alencar Junior AM; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital São Domingos, São Luís, MA, Brazil.; Dasa Oncologia, Brasília, DF, Brazil.; Hospital Universitário da Universidade Federal do Maranhão (UFMA), São Luís, MA, Brazil., de Andrade Mota AC; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Clínica AMO-DASA, Feira de Santana, BA, Brazil., Santucci B; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Instituto Paulista de Cancerologia, São Paulo, SP, Brazil., da Motta Girardi D; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Sírio-Libanês, Brasília, DF, Brazil., Herchenhorn D; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Oncologia D'Or, Rio de Janeiro, RJ, Brazil., Araújo DV; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital de Base de São José do Rio Preto/SP, São José do Rio Preto, São Paulo, SP, Brazil., Jardim DL; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Grupo Oncoclínicas, São Paulo, São Paulo, SP, Brazil., Bastos DA; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Sirio-Libanês de São Paulo, São Paulo, SP, Brazil., Rosa DR; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Grupo Oncoclínicas, Rio de Janeiro, RJ, Brazil., Schutz FA; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil., Kater FR; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil., da Silva Marinho F; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Grupo Oncoclínicas, Recife, PE, Brazil., Maluf FC; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil., de Oliveira FNG; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Grupo Oncoclínicas, Salvador, BA, Brazil., Vidigal F; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Dasa Oncologia, Brasília, DF, Brazil., Morbeck IAP; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Grupo Oncoclínicas, Brasília, DF, Brazil., Rinck Júnior JA; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; AC Camargo Cancer Center, São Paulo, SP, Brazil., Costa LAGA; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Oncologia D'Or, Fortaleza, CE, Brazil., Maia MCDF; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital do Câncer Porto Dias, Belém, PA, Brazil., Zereu M; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, RS, Brazil., Freitas MRP; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Centro Especializado de Oncologia de Florianópolis, Florianópolis, SC, Brazil., Dias MSF; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Grupo Oncoclínicas, Rio de Janeiro, RJ, Brazil., Tariki MS; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; AC Camargo Cancer Center, São Paulo, SP, Brazil., Muniz P; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Grupo Oncoclínicas, São Paulo, São Paulo, SP, Brazil.; Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., Beato PMM; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Amaral Carvalho, Jaú, SP, Brazil., Lages PSM; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Grupo Oncoclínicas, Brasília, DF, Brazil., Velho PI; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.; Johns Hopkins University, Baltimore, MD, USA., de Carvalho RS; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil., Mariano RC; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil., de Araújo Cavallero SR; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Adventista de Belém, Belém, PA, Brazil., Oliveira TM; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital São Rafael, Salvador, BA, Brazil., Souza VC; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Instituto D'Or de Ensino e Pesquisa, Salvador, BA, Brazil., Smaletz O; Latin American Cooperative Oncology Group, Genitourinary Group (LACOG-GU), Av. Brigadeiro Faria Lima, Vila Olímpia, São Paulo, SP, 4300, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., de Cássio Zequi S; AC Camargo Cancer Center, São Paulo, SP, Brazil.; National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, AC Camargo Cancer Center, São Paulo, SP, Brazil.
المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Apr 09; Vol. 150 (4), pp. 183. Date of Electronic Publication: 2024 Apr 09.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/pathology, Humans ; Latin America ; Consensus ; Sunitinib
-
2دورية أكاديمية
المؤلفون: Nabavi N; Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.; Radiation Sciences Research Center, AJA University of Medical Sciences, Tehran 14117-18541, Iran., Mahdavi SR; Department of Medical Physics, Radiation Biology Research Center, Iran University of Medical Sciences, Tehran 14117-18541, Iran., Ardalan MA; Department of Internal Medicine, School of Medicine, AJA University of Medical Sciences, Tehran 14117-18541, Iran., Chamanara M; Department of Pharmacology, School of Medicine, AJA University of Medical Sciences, Tehran 14117-18541, Iran., Mosaed R; Department of Clinical Pharmacy, School of Medicine, AJA University of Medical Sciences, Tehran 14117-18541, Iran., Lara A; Hospital Sírio-Libanês, São Paulo 01308-050, Brazil.; Hospital do Câncer UOPECCAN, Cascavel 85806-300, Brazil., Bastos D; Oncology Department, Hospital Sirio-Libanês, São Paulo 01308-050, Brazil., Harsini S; BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada., Askari E; Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran., Velho PI; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD 21231, USA.; Hospital Moinhos de Vento, Porto Alegre 90035-000, Brazil., Bagheri H; Radiation Sciences Research Center, AJA University of Medical Sciences, Tehran 14117-18541, Iran.; School of Medicine, AJA University of Medical Sciences, Tehran 14118-13389, Iran.
المصدر: Biomedicines [Biomedicines] 2023 Jul 24; Vol. 11 (7). Date of Electronic Publication: 2023 Jul 24.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
-
3دورية أكاديمية
المؤلفون: Talukder R; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA., Makrakis D; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA., Diamantopoulos LN; Department of Medicine, University of Pittsburgh, Pittsburgh, PA., Carril-Ajuria L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., De Kouchkovsky I; Division of Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA., Koshkin VS; Division of Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA., Park JJ; Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI., Alva A; Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA., Stewart TF; Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, CA., McKay RR; Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, CA., Santos VS; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT., Agarwal N; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT., Jain J; Department of Medicine, University of Iowa, Iowa City, IA., Zakharia Y; Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Devitt ME; Division of Hematology/Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA., Grant M; Department of Surgery and Cancer, Imperial College London, London, UK., Lythgoe MP; Department of Surgery and Cancer, Imperial College London, London, UK., Pinato DJ; Department of Surgery and Cancer, Imperial College London, London, UK., Nelson A; Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Hoimes CJ; Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH; Division of Medical Oncology, Duke University, Durham, NC., Shreck E; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY., Gartrell BA; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY., Sankin A; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY., Tripathi A; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK., Zakopoulou R; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Bamias A; 2nd Propaedeutic Dept of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Murgic J; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, School of Dental Medicine, Zagreb, Croatia., Fröbe A; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, School of Dental Medicine, Zagreb, Croatia., Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar Research Institute, Barcelona, Spain., Drakaki A; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA., Liu S; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA., Kumar V; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Lorenzo GD; Oncology University of Molise and ASL, Salerno, Italy., Joshi M; Division of Hematology/Oncology, Department of Medicine, Penn State Cancer Institute, Hershey, PA., Velho PI; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Buznego LA; Hospital Universitario Marques de Valdecilla. IDIVAL. Santander, Spain., Duran I; Hospital Universitario Marques de Valdecilla. IDIVAL. Santander, Spain., Moses M; Deming Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA., Barata P; Deming Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA., Sonpavde G; Genitourinary Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Yu EY; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Wright JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Urology, University of Washington, Seattle, WA., Grivas P; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Electronic address: pgrivas@uw.edu., Khaki AR; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Division of Oncology, Department of Medicine, Stanford University, Palo Alto, CA. Electronic address: alikhaki@stanford.edu.
المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2022 Apr; Vol. 20 (2), pp. 165-175. Date of Electronic Publication: 2021 Dec 17.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Transitional Cell*/drug therapy , Urinary Bladder Neoplasms*/pathology, Adjuvants, Immunologic ; Administration, Intravesical ; BCG Vaccine/therapeutic use ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Neoplasm Recurrence, Local/pathology ; Retrospective Studies
-
4تقرير
المؤلفون: Gongora ABL; Department of Oncology, Hospital Sírio-Libanês, São Paulo, Brazil. Electronic address: alineblara@yahoo.com.br., Marshall CH; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD., Velho PI; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD; Department of Oncology, Hospital Moinhos de Vento, Porto Alegre, Brazil., Lopes CDH; Department of Oncology, Hospital Sírio-Libanês, São Paulo, Brazil., Marin JF; Department of nuclear medicine, Hospital Sírio-Libanês, São Paulo, Brazil., Camargo AA; Molecular Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil., Bastos DA; Department of Oncology, Hospital Sírio-Libanês, São Paulo, Brazil., Antonarakis ES; Department of Medicine, Division of Hematology/Oncology and Transplantation, University of Minnesota, Minneapolis, MN.
المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2022 Apr; Vol. 20 (2), pp. 183-188. Date of Electronic Publication: 2021 Dec 24.
نوع المنشور: Case Reports
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
-
5دورية أكاديمية
المؤلفون: Markowski MC; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; mmarko12@jhmi.edu., Velho PI; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Department of Medical Oncology, Hospital Moinhos de Vento, Porto Alegre, Brazil., Eisenberger MA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Pomper MG; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and., Pienta KJ; James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Gorin MA; James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Antonarakis ES; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Denmeade SR; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Rowe SP; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and.
المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Sep 01; Vol. 62 (9), pp. 1270-1273. Date of Electronic Publication: 2021 Jan 15.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med
مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography* , Prostatic Neoplasms, Castration-Resistant*/diagnostic imaging , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology , Disease Progression* , Neoplasm Metastasis* , Lysine*/analogs & derivatives, Humans ; Male ; Aged ; Middle Aged ; Androgens ; Urea/analogs & derivatives
-
6دورية أكاديمية
المؤلفون: Deek MP; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Taparra K; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Phillips R; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Velho PI; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gao RW; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Deville C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Song DY; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Greco S; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Carducci M; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Eisenberger M; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., DeWeese TL; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Denmeade S; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pienta K; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Paller CJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Antonarakis ES; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Olivier KR; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Park SS; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Stish BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. Electronic address: Stish.Bradley@mayo.edu.
المصدر: European urology oncology [Eur Urol Oncol] 2021 Jun; Vol. 4 (3), pp. 447-455. Date of Electronic Publication: 2020 Jun 11.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
-
7دورية أكاديمية
المؤلفون: Velho PI; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Moinhos de Vento Hospital, Porto Alegre, Brazil., Bastos DA; Sirio Libanes Hospital, Sao Paulo, Brazil., Antonarakis ES; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
المصدر: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2021 Apr; Vol. 19 (4), pp. 228-240.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Androgen Receptor Antagonists/*therapeutic use , Antineoplastic Agents/*therapeutic use , Prostatic Neoplasms/*drug therapy , Receptors, Androgen/*metabolism , Signal Transduction/*drug effects, Androgen Receptor Antagonists/pharmacology ; Animals ; Antineoplastic Agents/pharmacology ; Humans ; Male ; Molecular Targeted Therapy/methods ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Testosterone/pharmacology ; Testosterone/therapeutic use
-
8دورية أكاديمية
المؤلفون: Wei XX; Dana-Farber Cancer Institute, Boston, Massachusetts., Werner L; Dana-Farber Cancer Institute, Boston, Massachusetts., Teo MY; Memorial Sloan Kettering Cancer Center, New York, New York., Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, New York., Koshkin VS; University of California San Francisco, San Francisco, California., Grivas P; University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington., Szabados B; Barts Cancer Centre, Queen Mary University of London, London, United Kingdom., Morrison L; Barts Cancer Centre, Queen Mary University of London, London, United Kingdom., Powles T; Barts Cancer Centre, Queen Mary University of London, London, United Kingdom., Carril-Ajuria L; Universitario de Octubre, Madrid, Spain., Castellano D; Universitario de Octubre, Madrid, Spain., Velho PI; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Hospital Moinhos de Vento, Porto Alegre, Brazil., Hahn NM; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Hospital Moinhos de Vento, Porto Alegre, Brazil., McKay RR; University of California San Diego, La Jolla, California., Raggi D; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Kanesvaran R; National Cancer Centre Singapore, Singapore, Singapore., Alerasool P; Tisch Cancer Institute at Mount Sinai, New York, New York., Gaines J; Tisch Cancer Institute at Mount Sinai, New York, New York., Galsky M; Tisch Cancer Institute at Mount Sinai, New York, New York., Bellmunt J; Dana-Farber Cancer Institute, Boston, Massachusetts., Sonpavde G; Dana-Farber Cancer Institute, Boston, Massachusetts.
المصدر: The Journal of urology [J Urol] 2021 Feb; Vol. 205 (2), pp. 414-419. Date of Electronic Publication: 2020 Sep 16.
نوع المنشور: Historical Article; Journal Article; Multicenter Study
بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Carboplatin/*administration & dosage , Carcinoma, Transitional Cell/*drug therapy , Carcinoma, Transitional Cell/*secondary , Immune Checkpoint Inhibitors/*administration & dosage , Urinary Bladder Neoplasms/*drug therapy , Urinary Bladder Neoplasms/*pathology, Drug Therapy, Combination ; Female ; History, 18th Century ; Humans ; Male ; Retrospective Studies
-
9دورية أكاديمية
عنوان ترانسليتريتد: Qualidade de vida e desfechos em longo prazo após hospitalização por COVID-19: Protocolo para um estudo de coorte prospectivo (Coalizão VII).
المؤلفون: Rosa RG; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil.; Brazilian Research in Intensive Care Network (BRICNet) - São Paulo (SP), Brasil., Robinson CC; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Veiga VC; Brazilian Research in Intensive Care Network (BRICNet) - São Paulo (SP), Brasil.; BP - A Beneficência Portuguesa de São Paulo - São Paulo (SP), Brasil., Cavalcanti AB; Brazilian Research in Intensive Care Network (BRICNet) - São Paulo (SP), Brasil.; Instituto de Pesquisa, HCor-Hospital do Coração - São Paulo (SP), Brasil., Azevedo LCP; Brazilian Research in Intensive Care Network (BRICNet) - São Paulo (SP), Brasil.; Instituto de Educação e Pesquisa, Hospital Sírio-Libanês - São Paulo (SP), Brasil., Machado FR; Brazilian Research in Intensive Care Network (BRICNet) - São Paulo (SP), Brasil.; Departamento de Anestesiologia, Dor e Terapia Intensiva, Universidade Federal de São Paulo - São Paulo (SP), Brasil., Berwanger O; Organização de Pesquisa Acadêmica, Hospital Israelita Albert Einstein - São Paulo (SP), Brasil., Avezum Á; Centro Internacional de Pesquisa, Hospital Alemão Oswaldo Cruz - São Paulo (SP), Brasil., Lopes RD; Brazilian Clinical Research Institute - São Paulo (SP), Brasil.; Instituto Duke de Pesquisa Clínica, Duke University Medical Center - Durham, NC, Estados Unidos., Lisboa TC; Brazilian Research in Intensive Care Network (BRICNet) - São Paulo (SP), Brasil.; Instituto de Pesquisa, HCor-Hospital do Coração - São Paulo (SP), Brasil., Teixeira C; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil.; Brazilian Research in Intensive Care Network (BRICNet) - São Paulo (SP), Brasil., Zampieri FG; Brazilian Research in Intensive Care Network (BRICNet) - São Paulo (SP), Brasil.; Instituto de Pesquisa, HCor-Hospital do Coração - São Paulo (SP), Brasil., Tomazini BM; Instituto de Educação e Pesquisa, Hospital Sírio-Libanês - São Paulo (SP), Brasil., Kawano-Dourado L; Instituto de Pesquisa, HCor-Hospital do Coração - São Paulo (SP), Brasil., Schneider D; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Souza D; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Santos RDRMD; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Silva SSD; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Trott G; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Gimenes BDP; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Souza AP; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Barroso BM; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Costa LS; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Brognoli LG; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Pelliccioli MP; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Studier NDS; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Schardosim RFC; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Haubert TA; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Pallaoro VEL; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Oliveira DM; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Velho PI; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Medeiros GS; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Gazzana MB; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Zavascki AP; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Pitrez PM; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Oliveira RP; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Polanczyk CA; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Nasi LA; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Hammes LS; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil., Falavigna M; Hospital Moinhos de Vento - Porto Alegre (RS), Brasil.
المصدر: Revista Brasileira de terapia intensiva [Rev Bras Ter Intensiva] 2021 Jan-Mar; Vol. 33 (1), pp. 31-37.
نوع المنشور: Journal Article; Multicenter Study
بيانات الدورية: Publisher: Associação de Medicina Intensiva Brasileira Country of Publication: Brazil NLM ID: 9506692 Publication Model: Print Cited Medium: Internet ISSN: 1982-4335 (Electronic) Linking ISSN: 0103507X NLM ISO Abbreviation: Rev Bras Ter Intensiva Subsets: MEDLINE
مواضيع طبية MeSH: Quality of Life*, COVID-19/*complications, Adult ; Brazil ; COVID-19/mortality ; Cardiovascular Diseases/etiology ; Cause of Death ; Follow-Up Studies ; Humans ; Patient Readmission ; Patient Reported Outcome Measures ; Prospective Studies ; Randomized Controlled Trials as Topic ; Return to Work ; Sample Size ; Survivors ; Telephone
-
10دورية أكاديمية
المؤلفون: Bonadioa RC; https://orcid.org/0000-0001-5818-922X., Velho PI; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X., Marta GN; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X., Nardo M; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X., Souza MC; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X., Muniz DQ; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X., Bezerra RO; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X., Bispo RK; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X., Faraj SF; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X., Bastos DA; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X., Dzik C; Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, Av Dr Arnaldo 251, São Paulo 01246-000, Brazil.; https://orcid.org/0000-0001-5818-922X.
المصدر: Ecancermedicalscience [Ecancermedicalscience] 2019 Nov 04; Vol. 13, pp. 973. Date of Electronic Publication: 2019 Nov 04 (Print Publication: 2019).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: ecancer Country of Publication: England NLM ID: 101392236 Publication Model: eCollection Cited Medium: Print ISSN: 1754-6605 (Print) Linking ISSN: 17546605 NLM ISO Abbreviation: Ecancermedicalscience Subsets: PubMed not MEDLINE